Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05685797

Biomarker Study in Patients With Trigeminal Neuralgia

Conditions: Trigeminal Neuralgia

Sex: All

Ages: 20 Years – 80 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 30

Sponsor: Keimyung University Dongsan Medical Center

Summary

Investigators performed this study to investigate the expression levels inflammatory cytokine and neurotransmitters (calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and β-endorphin) in peripheral blood of participants with primary trigeminal neuralgia (TN).

Eligibility Criteria

Inclusion Criteria:TN patients with NRS more than 4TN patients who failed medical treatmentTN patients showing severe adverse reaction with medicationExclusion Criteria:Patients showing allergic reaction to local anestheticsPatients with coagulation abnormality

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05685797). StuddyBuddy aggregates publicly available trial information.